Park M, Song W, Ahn H, Kim S. Drug toxicity prediction based on genotype-phenotype differences between preclinical models and humans. EBioMedicine. 2025 Oct 28;121:105994.
Lee J, Kim D, Kong J, Ha D, Kim I, Park M, Lee K, Im SH, Kim S. Cell-cell communication network-based interpretable machine learning predicts cancer patient response to immune checkpoint inhibitors.Sci Adv. 2024 Feb 2;10(5):eadj0785. doi: 10.1126/sciadv.a
Park M, Kim D, Kim I, Im SH, Kim S. Drug approval prediction based on the discrepancy in gene perturbation effects between cells and humans.
Kim D, Ha D, Lee K, Lee H, Kim I, Kim S. An evolution-based machine learning to identify cancer type-specific driver mutations.Brief Bioinform. 2023 Jan 19;24(1):bbac593. doi: 10.1093/bib/bbac593.
Kong J, Ha D, Lee J, Kim I, Park M, Im SH, Shin K, Kim S. Network-based machine learning approach to predict immunotherapy response in cancer patients. Nat Commun. 2022 Jun 28;13(1):3703. doi: 10.1038/s41467-022-31535-6.